Temperature‑Sensitive Drugs Drive Up Costs and Effort in Pharma Logistics
New active ingredients such as mRNA vaccines and biologics raise the demand for seamless temperature control, increase operational effort and require extensive process adjustments.
What’s Changing
The growing number of temperature‑sensitive medicines – including biologics, mRNA vaccines, gene therapies and GLP‑1 agents – is reshaping requirements across the entire supply chain. Compared with conventional tablets, these products must be kept within tightly defined temperature ranges throughout the transport journey (e.g., 2 °C ± 2 °C or –70 °C ± 5 °C). This means that not only the cooling capacity of transport vehicles, but also intermediate storage, handling processes and final delivery need to be equipped with real‑time temperature monitoring. At the same time, policymakers are calling for uniform EU standards to make cross‑border shipments transparent and traceable.
Logistics providers are responding by expanding their service portfolios. A concrete example is C.H. Robinson’s acquisition of specialist logistics firm DeSpir Logistics to grow its healthcare business. The focus is on controlled transports that combine continuous temperature monitoring, seamless documentation and high security standards. Experts expect that supply‑chain digitisation – through IoT sensors, cloud‑based data platforms and automated reporting tools – will be increasingly required to meet regulatory mandates and minimise the risk of temperature excursions.
What It Costs
The source does not provide published figures for the additional costs generated by the new temperature requirements. Nonetheless, the cost mechanism can be outlined: each extra refrigerated or frozen container, every real‑time telemetry unit and each software licence for temperature monitoring add to operating expenses. In addition, indirect costs arise from higher training effort for staff, expanded quality and audit reports and possible surcharge models from transport providers offering specialised services. Because no concrete price data have been released, companies can only estimate the financial impact based on internal calculations or vendor cost proposals.
Another cost driver is the need to modernise existing warehousing and transport infrastructure. Replacing standard shelving with temperature‑controlled systems, installing redundant cooling units and integrating sensor networks all require investment that can vary widely depending on company size. Without published numbers, the exact magnitude of the added cost remains speculative; firms should therefore solicit quotes from specialised logistics partners early and model total costs over a multi‑year horizon.
What Breaks in the Process
Switching to temperature‑critical logistics processes can strain existing IT interfaces and ERP systems. Many companies still rely on standard transport‑management systems (TMS) that cannot handle real‑time temperature data. Integrating new sensor and monitoring solutions often requires adjustments to interfaces, databases and reporting tools, which can trigger temporary system outages or data inconsistencies. In addition, staff in warehousing, shipping and customer service need training on the new technologies – a process that can cause productivity losses during the transition.
A further risk is potential supply‑chain disruption during migration. Replacing existing refrigerated vehicles or signing new transport contracts with specialised providers can lead to delivery delays. Documentation requirements also evolve: the seamless recording of temperature data often needs to be aligned with regulatory mandates (e.g., EU‑GMP), adding training and audit effort for quality and compliance teams. The impact falls primarily on logistics and IT departments, but also on procurement, quality management and senior management, who must weigh the risks and costs.
What a Switch Demands
Moving to a temperature‑secured supply chain requires structured project management. Companies should start with an inventory of all affected products and processes to scope the necessary adjustments. Based on that analysis, they can select appropriate technology partners for sensors, data platforms and refrigerated vehicles. The effort can range from three to twelve months depending on company size, with the implementation phase split into several milestones: hardware procurement, TMS integration, staff training and final process validation. Crucially, senior management must define clear responsibilities and allocate a budget for the investments.
During the transition, internal stakeholders – especially logistics, IT, quality assurance and procurement – must work closely to avoid interface issues and ensure regulatory compliance. Companies should also negotiate new service‑level agreements with their transport partners early on to make delivery times and costs transparent. The switch therefore demands not only financial resources but also organisational change, clear communication channels and continuous monitoring to safeguard the quality of temperature‑critical deliveries over the long term.
